| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.067 | 0.08 |
| mRNA | AZD8055 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.08 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.093 | 0.08 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | 0.057 | 0.08 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.08 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.052 | 0.08 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.059 | 0.09 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.09 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.09 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.09 |